The growing knowledge on the mechanisms of gene silencing and gene regulation by non-coding RNAs (ncRNA), mainly small interfering RNA (siRNA) and microRNA (miRNA), is providing a significant boost to the development of new therapeutic strategies for the treatment of cancer. However, the design of RNA-based therapeutics is hampered by biopharmaceutical issues, thus requiring the use of suitable delivery strategies. In this regards, lipid nanovectors have been successfully investigated to deliver RNA in different forms of cancer. Compared to other biomaterials, lipids offer advantages such as biocompatibility, biodegradability, easy production, low cost, limited toxicity and immunogenicity. The possibility to formulate these materials in the form of nanovectors allows overcoming biopharmaceutical issues associated to the therapeutic use of RNA, with the possibility to target tumors. This review takes stock of the main lipid nanovectors proposed to deliver ncRNA. For each considered delivery strategy, the rational design and the most meaningful in vitro and in vivo results are reported and discussed.

Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer / Campani, Virginia; Salzano, Giuseppina; Lusa, Sara; DE ROSA, Giuseppe. - In: NANOMATERIALS. - ISSN 2079-4991. - 6:7(2016), p. 131. [10.3390/nano6070131]

Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer

CAMPANI, VIRGINIA
Primo
;
SALZANO, GIUSEPPINA;lusa, sara;DE ROSA, GIUSEPPE
Ultimo
2016

Abstract

The growing knowledge on the mechanisms of gene silencing and gene regulation by non-coding RNAs (ncRNA), mainly small interfering RNA (siRNA) and microRNA (miRNA), is providing a significant boost to the development of new therapeutic strategies for the treatment of cancer. However, the design of RNA-based therapeutics is hampered by biopharmaceutical issues, thus requiring the use of suitable delivery strategies. In this regards, lipid nanovectors have been successfully investigated to deliver RNA in different forms of cancer. Compared to other biomaterials, lipids offer advantages such as biocompatibility, biodegradability, easy production, low cost, limited toxicity and immunogenicity. The possibility to formulate these materials in the form of nanovectors allows overcoming biopharmaceutical issues associated to the therapeutic use of RNA, with the possibility to target tumors. This review takes stock of the main lipid nanovectors proposed to deliver ncRNA. For each considered delivery strategy, the rational design and the most meaningful in vitro and in vivo results are reported and discussed.
2016
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer / Campani, Virginia; Salzano, Giuseppina; Lusa, Sara; DE ROSA, Giuseppe. - In: NANOMATERIALS. - ISSN 2079-4991. - 6:7(2016), p. 131. [10.3390/nano6070131]
File in questo prodotto:
File Dimensione Formato  
2016_Campani et al Nanomaterials.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 714.04 kB
Formato Adobe PDF
714.04 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/635424
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 25
social impact